Based on these findings, we propose that BAP31 regulates the PINK1–Parkin signaling pathway via the transcription factor EN1, thereby contributing to the amelioration of behavioral deficits and pathological alterations in PD mouse models. The gene discussed is PRKN; the disease is Parkinson disease.